Belgium· BE-AMP-SAM204145-00
Virgan 1.5 mg/g
A ganciclovir product containing ganciclovir, registered in Belgium by Laboratoires Théa. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ganciclovir is registered in 9 of 19 countries.
Countries holding a registration under ATC S01AD09 (ganciclovir), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Ganciclovir · ATC S01AD09
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ganciclovir
- Manufacturer
- Laboratoires Théa
- Country
- Belgium (BE)
- ATC code
- S01AD09
- ATC class
- Ganciclovir
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb0770396
- be_apb1649458EUR 16.61
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ganciclovir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandVirgan 1,5 mg/g żel do oczuMedezin Sp. z o.o.
- SpainVIRGAN 1,5 mg/g GEL OFTALMICOLaboratoires Thea
- FinlandVirgan
- FranceVIRGAN 1,5 mg/g, gel ophtalmiqueTHEA
- NorwayVirganLaboratoires Théa
- SwitzerlandVirgan 1.5 mg/g, gel ophtalmiqueTHEA Pharma S.A.
- United StatesZIRGANBausch & Lomb Incorporated
- CzechiaVIRGANLaboratoires Thea, Clermont-Ferrand
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Cymevene, Ganciclovir Oresund Pharma
- Bulgaria · Ганцикловир Ромфарм
- Czechia · Cymevene, Virgan
- Germany · Cymeven I.V., Ganciclovir Accord
- Denmark · Cymevene, Ganciclovir Oresund Pharma
- Spain · Cymevene, Ganciclovir Accord
- Finland · Cymevene, Ganciclovir Bioglan
- France · Cymevan, Ganciclovir Hikma
- United Kingdom (Northern Ireland) · Cymevene, Ganciclovir Kensington Pharma
- Greece · Gancilen, Virgan
- Croatia · Cymevene
- Hungary · Cymevene, Ganciclovir Rompharm
- Ireland · Cymevene
- Italy · Citovirax, Ganciclovir Accord
- Luxembourg · Cymevene, Virgan
- Netherlands · Cymevene, Ganciclovir Sandoz
- Norway · Cymevene, Ganciclovir Bioglan
- Poland · Cymevene, Ganciclovir Accord
- Portugal · Cymevene, Ganciclovir Accord
- Romania · Ganciclovir Rompharm, Virgan
- Sweden · Cymevene, Ganciclovir Bioglan
- Slovakia · Cymevene
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/66ebf1d0-854e-48b4-96d4-124352e4e43e GET /v1/drugs/66ebf1d0-854e-48b4-96d4-124352e4e43e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye gel",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Virgan 1.5 mg/g",
"name_fr": "Virgan 1.5 mg/g",
"name_nl": "Virgan 1.5 mg/g",
"amp_code": "SAM204145-00",
"strengths": [
"1.5000",
"0.0750",
"1.5000",
"50.0000"
],
"pack_count": 1,
"substances": [
"Ganciclovir",
"Benzalkonium Chloride",
"Sodium Hydroxide",
"Sorbitol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ganciclovir",
"authorisation_numbers": [
"BE204145"
]
}See everything about ganciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.